Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response
暂无分享,去创建一个
S. Subramanian | Mona Moieni | Nelli Boykoff | Saskia Karen Subramanian | Mona Moieni | Nelli Boykoff
[1] M Abdolell,et al. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Wieneke,et al. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer , 1995 .
[3] S. Sereika,et al. Cognitive impairment associated with adjuvant therapy in breast cancer , 2006, Psycho-oncology.
[4] Michael E. Phelps,et al. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy , 2007, Breast Cancer Research and Treatment.
[5] M. Muller,et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma , 1999, Cancer.
[6] R. Theriault,et al. ‘Chemobrain’ in breast carcinoma? , 2004, Cancer.
[7] T. Ahles,et al. Renaming “Chemobrain” , 2007, Cancer investigation.
[8] I. Tannock,et al. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment , 2006, Psycho-oncology.
[9] S. Allan,et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer , 2006, British Journal of Cancer.
[10] Andrew J Saykin,et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] V. Shilling,et al. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. , 2007, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[12] P. Ganz. Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? , 1998, Journal of the National Cancer Institute.
[13] V. Shilling,et al. The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study. , 2005, Breast.
[14] S. E. Grober. Resources for treatment of chemotherapy-related cognitive difficulty. , 2002, Cancer practice.
[15] S. Sereika,et al. Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review. , 2001, Journal of pain and symptom management.
[16] J. Holland,et al. Cognitive Function of Older Patients Receiving Adjuvant Chemotherapy for Breast Cancer: A Pilot Prospective Longitudinal Study , 2006, Journal of the American Geriatrics Society.
[17] M. Fitch,et al. Patients' experiences with cognitive changes after chemotherapy. , 2008, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.
[18] Paul Maruff,et al. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature , 2005, Brain and Cognition.
[19] P. Jacobsen,et al. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early‐stage breast carcinoma , 2005, Cancer.
[20] C. Nelson,et al. Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions , 2007, Palliative and Supportive Care.
[21] M. Lorentzon. Doing Qualitative Research , 1993 .
[22] R. Raffa,et al. Is ‘chemo‐fog’/‘chemo‐brain’ caused by cancer chemotherapy? , 2006, Journal of clinical pharmacy and therapeutics.
[23] P. Ganz,et al. Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen , 2004, Journal of clinical and experimental neuropsychology.
[24] Y. Ohashi,et al. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms , 2005, Breast cancer.
[25] D. Butterfield,et al. Adriamycin‐mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain , 2007, Journal of neurochemistry.
[26] G. Jackson. Chemo brain - a psychotropic drug phenomenon? , 2008, Medical hypotheses.
[27] David Schiff,et al. Neurologic complications of chemotherapy agents , 2007, Current opinion in neurology.
[28] S. Rodenhuis,et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. , 1998, Journal of the National Cancer Institute.